LifeClean International（LCLEAN）株式概要ライフクリーン・インターナショナルAB（publish）は、スウェーデン国内外で消毒製品の研究、製造、マーケティング、販売を行っている。 詳細LCLEAN ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性1/6配当金0/6リスク分析過去5年間で収益は年間10.3%減少しました。 キャッシュランウェイが1年未満である 過去1年間で株主の希薄化は大幅に進んだ Swedish市場と比較して、過去 3 か月間の株価の変動が非常に大きい+1 さらなるリスクすべてのリスクチェックを見るLCLEAN Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueSEK Current PriceSEK 0.05892.0% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-52m71m2016201920222025202620282031Revenue SEK 70.5mEarnings SEK 6.6mAdvancedSet Fair ValueView all narrativesLifeClean International AB (publ) 競合他社Recyctec HoldingSymbol: NGM:RECY BMarket cap: SEK 9.0mSvenska Aerogel HoldingSymbol: OM:AEROMarket cap: SEK 31.9mPhotocatSymbol: OM:PCATMarket cap: SEK 56.7mOrganoClickSymbol: OM:ORGCMarket cap: SEK 62.0m価格と性能株価の高値、安値、推移の概要LifeClean International過去の株価現在の株価SEK 0.05852週高値SEK 0.3852週安値SEK 0.046ベータ1.911ヶ月の変化-23.20%3ヶ月変化-3.36%1年変化-68.52%3年間の変化-99.17%5年間の変化-99.21%IPOからの変化-99.49%最新ニュースNew Risk • 13hNew major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 274% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr23m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Earnings have declined by 10% per year over the past 5 years. Shareholders have been substantially diluted in the past year (274% increase in shares outstanding). Market cap is less than US$10m (kr57.0m market cap, or US$6.09m).Reported Earnings • May 05First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: kr15.1m (up 2.0% from 1Q 2025). Net loss: kr6.67m (loss narrowed 27% from 1Q 2025).お知らせ • Apr 27LifeClean International AB (publ), Annual General Meeting, May 27, 2026LifeClean International AB (publ), Annual General Meeting, May 27, 2026, at 13:00 W. Europe Standard Time. Location: at born laws premises, strandvagen 7a, stockholm SwedenReported Earnings • Feb 09Full year 2025 earnings released: kr0.13 loss per share (vs kr0.97 loss in FY 2024)Full year 2025 results: kr0.13 loss per share (improved from kr0.97 loss in FY 2024). Revenue: kr55.4m (down 9.4% from FY 2024). Net loss: kr35.7m (loss narrowed 34% from FY 2024).Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Director Karin Fischer was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 24Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: kr9.49m (down 32% from 3Q 2024). Net loss: kr10.2m (loss narrowed 23% from 3Q 2024).最新情報をもっと見るRecent updatesNew Risk • 13hNew major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 274% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr23m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Earnings have declined by 10% per year over the past 5 years. Shareholders have been substantially diluted in the past year (274% increase in shares outstanding). Market cap is less than US$10m (kr57.0m market cap, or US$6.09m).Reported Earnings • May 05First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: kr15.1m (up 2.0% from 1Q 2025). Net loss: kr6.67m (loss narrowed 27% from 1Q 2025).お知らせ • Apr 27LifeClean International AB (publ), Annual General Meeting, May 27, 2026LifeClean International AB (publ), Annual General Meeting, May 27, 2026, at 13:00 W. Europe Standard Time. Location: at born laws premises, strandvagen 7a, stockholm SwedenReported Earnings • Feb 09Full year 2025 earnings released: kr0.13 loss per share (vs kr0.97 loss in FY 2024)Full year 2025 results: kr0.13 loss per share (improved from kr0.97 loss in FY 2024). Revenue: kr55.4m (down 9.4% from FY 2024). Net loss: kr35.7m (loss narrowed 34% from FY 2024).Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Director Karin Fischer was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 24Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: kr9.49m (down 32% from 3Q 2024). Net loss: kr10.2m (loss narrowed 23% from 3Q 2024).New Risk • Aug 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Swedish stocks, typically moving 36% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr35m free cash flow). Share price has been highly volatile over the past 3 months (36% average weekly change). Earnings have declined by 30% per year over the past 5 years. Shareholders have been substantially diluted in the past year (393% increase in shares outstanding). Market cap is less than US$10m (kr71.3m market cap, or US$7.44m).Reported Earnings • Jul 16Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: kr20.5m (down 2.3% from 2Q 2024). Net loss: kr7.18m (loss narrowed 44% from 2Q 2024).お知らせ • May 28LifeClean International AB (publ), Annual General Meeting, Jun 30, 2025LifeClean International AB (publ), Annual General Meeting, Jun 30, 2025, at 13:00 W. Europe Standard Time. Location: at born advokaters premises, strandvagen 7a, 102 45 stockholm. SwedenNew Risk • May 26New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 452% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr37m free cash flow). Share price has been highly volatile over the past 3 months (48% average weekly change). Negative equity (-kr12m). Earnings have declined by 34% per year over the past 5 years. Shareholders have been substantially diluted in the past year (452% increase in shares outstanding). Market cap is less than US$10m (kr50.2m market cap, or US$5.27m).Reported Earnings • May 21First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: kr15.1m (down 4.8% from 1Q 2024). Net loss: kr9.17m (loss narrowed 39% from 1Q 2024).New Risk • Apr 23New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -kr43m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr43m free cash flow). Share price has been highly volatile over the past 3 months (49% average weekly change). Negative equity (-kr3.6m). Earnings have declined by 37% per year over the past 5 years. Market cap is less than US$10m (kr13.5m market cap, or US$1.41m).Reported Earnings • Feb 20Full year 2024 earnings released: kr0.97 loss per share (vs kr0.94 loss in FY 2023)Full year 2024 results: kr0.97 loss per share (further deteriorated from kr0.94 loss in FY 2023). Revenue: kr62.0m (up 18% from FY 2023). Net loss: kr53.7m (loss widened 21% from FY 2023). Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 6.0% growth forecast for the Chemicals industry in Sweden. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 49% per year, which means it is performing significantly worse than earnings.お知らせ • Feb 20LifeClean International AB (publ), Annual General Meeting, Mar 21, 2025LifeClean International AB (publ), Annual General Meeting, Mar 21, 2025, at 08:00 W. Europe Standard Time. Location: at born advokater`s premises, strandvagen 7a, 102 45, stockholm. SwedenNew Risk • Dec 05New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: kr108.5m (US$9.97m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 39% per year over the past 5 years. Market cap is less than US$10m (kr108.5m market cap, or US$9.97m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr43m). Shareholders have been diluted in the past year (18% increase in shares outstanding).Price Target Changed • Nov 16Price target increased by 437% to kr36.00Up from kr6.70, the current price target is provided by 1 analyst. New target price is 1,381% above last closing price of kr2.43. Stock is down 63% over the past year. The company posted a net loss per share of kr0.94 last year.New Risk • Oct 27New major risk - Revenue and earnings growthEarnings have declined by 39% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 39% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr43m). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (kr207.5m market cap, or US$19.5m).Reported Earnings • Oct 25Third quarter 2024 earnings: Revenues miss analyst expectationsThird quarter 2024 results: Revenue: kr14.1m (up 39% from 3Q 2023). Net loss: kr13.3m (loss widened 11% from 3Q 2023). Revenue missed analyst estimates by 36%. Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Sweden.New Risk • Sep 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Swedish stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Negative equity (-kr8.1m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr40m). Currently unprofitable and not forecast to become profitable over next 2 years (kr10m net loss in 2 years). Share price has been volatile over the past 3 months (8.3% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (kr283.7m market cap, or US$27.8m).Major Estimate Revision • Sep 06Consensus revenue estimates increase by 13%The consensus outlook for revenues in fiscal year 2024 has improved. 2024 revenue forecast increased from kr72.0m to kr81.4m. Forecast losses expected to reduce from -kr1.00 to -kr0.90 per share. Chemicals industry in Sweden expected to see average net income growth of 36% next year. Consensus price target up from kr6.70 to kr8.00. Share price rose 13% to kr5.94 over the past week.Breakeven Date Change • Sep 03No longer forecast to breakevenThe analyst covering LifeClean International no longer expects the company to break even during the foreseeable future. The company was expected to make a profit of kr3.00m in 2026. New forecast suggests the company will make a loss of kr4.00m in 2026.Price Target Changed • Sep 02Price target increased by 14% to kr8.00Up from kr7.00, the current price target is provided by 1 analyst. New target price is 45% above last closing price of kr5.50. Stock is up 0.7% over the past year. The company is forecast to post a net loss per share of kr0.90 next year compared to a net loss per share of kr0.94 last year.Reported Earnings • Sep 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: kr21.0m (up 47% from 2Q 2023). Net loss: kr12.8m (loss widened 21% from 2Q 2023). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Sweden.New Risk • Aug 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Swedish stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr44m). Currently unprofitable and not forecast to become profitable over next 2 years (kr3.8m net loss in 2 years). Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (5.0% increase in shares outstanding). Market cap is less than US$100m (kr221.9m market cap, or US$21.0m).分析記事 • May 09LifeClean International (STO:LCLEAN) Is Making Moderate Use Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...New Risk • Apr 09New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr40m free cash flow). Earnings have declined by 42% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (6.3% increase in shares outstanding). Revenue is less than US$5m (kr53m revenue, or US$5.0m). Market cap is less than US$100m (kr430.9m market cap, or US$40.9m).Reported Earnings • Feb 21Full year 2023 earnings released: kr0.94 loss per share (vs kr0.83 loss in FY 2022)Full year 2023 results: kr0.94 loss per share (further deteriorated from kr0.83 loss in FY 2022). Revenue: kr52.5m (up 11% from FY 2022). Net loss: kr44.2m (loss widened 23% from FY 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Chemicals industry in Sweden. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Board Member Petra Sas was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Price Target Changed • Nov 28Price target decreased by 29% to kr6.70Down from kr9.50, the current price target is provided by 1 analyst. New target price is 29% above last closing price of kr5.20. Stock is down 43% over the past year. The company posted a net loss per share of kr0.83 last year.Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: kr10.4m (up 17% from 3Q 2022). Net loss: kr11.9m (loss widened 44% from 3Q 2022). Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Sweden.New Risk • Aug 31New minor risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow. Free cash flow: -kr33m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr33m). Currently unprofitable and not forecast to become profitable over next 2 years (kr3.0m net loss in 2 years). Share price has been volatile over the past 3 months (9.5% average weekly change). Shareholders have been diluted in the past year (9.1% increase in shares outstanding). Revenue is less than US$5m (kr47m revenue, or US$4.3m). Market cap is less than US$100m (kr282.6m market cap, or US$25.8m).New Risk • Jul 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Swedish stocks, typically moving 9.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr5.0m net loss in 2 years). Share price has been volatile over the past 3 months (9.5% average weekly change). Shareholders have been diluted in the past year (9.1% increase in shares outstanding). Revenue is less than US$5m (kr48m revenue, or US$4.5m). Market cap is less than US$100m (kr341.2m market cap, or US$32.4m).Reported Earnings • Feb 19Full year 2022 earnings released: kr0.83 loss per share (vs kr0.83 loss in FY 2021)Full year 2022 results: kr0.83 loss per share (further deteriorated from kr0.83 loss in FY 2021). Revenue: kr48.3m (down 18% from FY 2021). Net loss: kr36.1m (loss widened 1.0% from FY 2021). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in Sweden.Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Board Member Petra Sas was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 06Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: kr9.10m (down 21% from 3Q 2021). Net loss: kr8.31m (loss narrowed 1.3% from 3Q 2021). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Chemicals industry in Sweden.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. No independent directors (4 non-independent directors). Board member Jan Sjowall was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Feb 18Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: kr0.78 loss per share (down from kr0.14 loss in FY 2020). Revenue: kr55.3m (up 69% from FY 2020). Net loss: kr32.8m (loss widened kr29.6m from FY 2020). Revenue missed analyst estimates by 52%.Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a decent third quarter result with improved revenues, although losses increased and control over costs was weaker. Third quarter 2021 results: Revenue: kr12.1m (up 261% from 3Q 2020). Net loss: kr8.42m (loss widened 271% from 3Q 2020).Reported Earnings • Aug 20Second quarter 2021 earnings released: kr0.15 loss per share (vs kr0.76 profit in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and control over costs. Second quarter 2021 results: Revenue: kr18.9m (down 3.2% from 2Q 2020). Net loss: kr6.36m (down 215% from profit in 2Q 2020).Reported Earnings • May 07First quarter 2021 earnings releasedThe company reported a poor first quarter result with weaker earnings, revenues and control over costs. First quarter 2021 results: Revenue: kr12.0m (down 6.9% from 1Q 2020). Net loss: kr6.99m (down 338% from profit in 1Q 2020).分析記事 • Apr 19LifeClean International AB (publ)'s (STO:LCLEAN) About To Shift From Loss To ProfitLifeClean International AB (publ) ( STO:LCLEAN ) is possibly approaching a major achievement in its business, so we...Reported Earnings • Mar 29Full year 2020 earnings released: kr0.14 loss per shareThe company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: kr32.7m (up kr29.0m from FY 2019). Net loss: kr3.20m (loss narrowed 69% from FY 2019).Reported Earnings • Feb 21Full year 2020 earnings released: kr0.14 loss per shareThe company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: kr32.7m (up kr29.0m from FY 2019). Net loss: kr3.20m (loss narrowed 69% from FY 2019).Is New 90 Day High Low • Jan 27New 90-day low: kr9.60The company is down 6.0% from its price of kr10.25 on 28 October 2020. The Swedish market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.Is New 90 Day High Low • Jan 04New 90-day low: kr9.79The company is down 23% from its price of kr12.70 on 06 October 2020. The Swedish market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.分析記事 • Jan 02Should LifeClean International AB (publ) (STO:LCLEAN) Focus On Improving This Fundamental Metric?One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...株主還元LCLEANSE ChemicalsSE 市場7D-4.0%1.6%3.2%1Y-68.5%-14.6%14.4%株主還元を見る業界別リターン: LCLEAN過去 1 年間で-14.6 % の収益を上げたSwedish Chemicals業界を下回りました。リターン対市場: LCLEANは、過去 1 年間で14.4 % のリターンを上げたSwedish市場を下回りました。価格変動Is LCLEAN's price volatile compared to industry and market?LCLEAN volatilityLCLEAN Average Weekly Movement23.3%Chemicals Industry Average Movement6.8%Market Average Movement6.3%10% most volatile stocks in SE Market13.3%10% least volatile stocks in SE Market3.7%安定した株価: LCLEANの株価は、 Swedish市場と比較して過去 3 か月間で変動しています。時間の経過による変動: LCLEANの weekly volatility ( 23% ) は過去 1 年間安定していますが、依然としてSwedishの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト201222Anders Lundstromwww.lifeclean.seライフクリーン・インターナショナルAB（publish）は、スウェーデン国内および国際的に消毒製品の研究、製造、マーケティング、販売を行っている。床、壁、設備、家具などの表面に対して、芽胞菌、真菌、バクテリア、バイオフィルム、ウイルスを殺菌する表面消毒剤を開発し、特許を取得している。同社はヨーロッパ、アラブ首長国連邦、サウジアラビア、韓国で製品を販売している。ライフクリーン・インターナショナルAB（publ）は2012年に設立され、スウェーデンのウッデバラに本社を置いている。もっと見るLifeClean International AB (publ) 基礎のまとめLifeClean International の収益と売上を時価総額と比較するとどうか。LCLEAN 基礎統計学時価総額SEK 59.07m収益（TTM）-SEK 33.16m売上高(TTM)SEK 54.62m1.1xP/Sレシオ-1.8xPER（株価収益率LCLEAN は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計LCLEAN 損益計算書（TTM）収益SEK 54.62m売上原価SEK 29.11m売上総利益SEK 25.51mその他の費用SEK 58.67m収益-SEK 33.16m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-0.032グロス・マージン46.71%純利益率-60.71%有利子負債／自己資本比率665.8%LCLEAN の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 10:26終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋LifeClean International AB (publ) 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Mats HyttingeRedeye
New Risk • 13hNew major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 274% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr23m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Earnings have declined by 10% per year over the past 5 years. Shareholders have been substantially diluted in the past year (274% increase in shares outstanding). Market cap is less than US$10m (kr57.0m market cap, or US$6.09m).
Reported Earnings • May 05First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: kr15.1m (up 2.0% from 1Q 2025). Net loss: kr6.67m (loss narrowed 27% from 1Q 2025).
お知らせ • Apr 27LifeClean International AB (publ), Annual General Meeting, May 27, 2026LifeClean International AB (publ), Annual General Meeting, May 27, 2026, at 13:00 W. Europe Standard Time. Location: at born laws premises, strandvagen 7a, stockholm Sweden
Reported Earnings • Feb 09Full year 2025 earnings released: kr0.13 loss per share (vs kr0.97 loss in FY 2024)Full year 2025 results: kr0.13 loss per share (improved from kr0.97 loss in FY 2024). Revenue: kr55.4m (down 9.4% from FY 2024). Net loss: kr35.7m (loss narrowed 34% from FY 2024).
Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Director Karin Fischer was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 24Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: kr9.49m (down 32% from 3Q 2024). Net loss: kr10.2m (loss narrowed 23% from 3Q 2024).
New Risk • 13hNew major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 274% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr23m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Earnings have declined by 10% per year over the past 5 years. Shareholders have been substantially diluted in the past year (274% increase in shares outstanding). Market cap is less than US$10m (kr57.0m market cap, or US$6.09m).
Reported Earnings • May 05First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: kr15.1m (up 2.0% from 1Q 2025). Net loss: kr6.67m (loss narrowed 27% from 1Q 2025).
お知らせ • Apr 27LifeClean International AB (publ), Annual General Meeting, May 27, 2026LifeClean International AB (publ), Annual General Meeting, May 27, 2026, at 13:00 W. Europe Standard Time. Location: at born laws premises, strandvagen 7a, stockholm Sweden
Reported Earnings • Feb 09Full year 2025 earnings released: kr0.13 loss per share (vs kr0.97 loss in FY 2024)Full year 2025 results: kr0.13 loss per share (improved from kr0.97 loss in FY 2024). Revenue: kr55.4m (down 9.4% from FY 2024). Net loss: kr35.7m (loss narrowed 34% from FY 2024).
Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Director Karin Fischer was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 24Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: kr9.49m (down 32% from 3Q 2024). Net loss: kr10.2m (loss narrowed 23% from 3Q 2024).
New Risk • Aug 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Swedish stocks, typically moving 36% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr35m free cash flow). Share price has been highly volatile over the past 3 months (36% average weekly change). Earnings have declined by 30% per year over the past 5 years. Shareholders have been substantially diluted in the past year (393% increase in shares outstanding). Market cap is less than US$10m (kr71.3m market cap, or US$7.44m).
Reported Earnings • Jul 16Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: kr20.5m (down 2.3% from 2Q 2024). Net loss: kr7.18m (loss narrowed 44% from 2Q 2024).
お知らせ • May 28LifeClean International AB (publ), Annual General Meeting, Jun 30, 2025LifeClean International AB (publ), Annual General Meeting, Jun 30, 2025, at 13:00 W. Europe Standard Time. Location: at born advokaters premises, strandvagen 7a, 102 45 stockholm. Sweden
New Risk • May 26New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 452% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr37m free cash flow). Share price has been highly volatile over the past 3 months (48% average weekly change). Negative equity (-kr12m). Earnings have declined by 34% per year over the past 5 years. Shareholders have been substantially diluted in the past year (452% increase in shares outstanding). Market cap is less than US$10m (kr50.2m market cap, or US$5.27m).
Reported Earnings • May 21First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: kr15.1m (down 4.8% from 1Q 2024). Net loss: kr9.17m (loss narrowed 39% from 1Q 2024).
New Risk • Apr 23New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -kr43m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr43m free cash flow). Share price has been highly volatile over the past 3 months (49% average weekly change). Negative equity (-kr3.6m). Earnings have declined by 37% per year over the past 5 years. Market cap is less than US$10m (kr13.5m market cap, or US$1.41m).
Reported Earnings • Feb 20Full year 2024 earnings released: kr0.97 loss per share (vs kr0.94 loss in FY 2023)Full year 2024 results: kr0.97 loss per share (further deteriorated from kr0.94 loss in FY 2023). Revenue: kr62.0m (up 18% from FY 2023). Net loss: kr53.7m (loss widened 21% from FY 2023). Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 6.0% growth forecast for the Chemicals industry in Sweden. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 49% per year, which means it is performing significantly worse than earnings.
お知らせ • Feb 20LifeClean International AB (publ), Annual General Meeting, Mar 21, 2025LifeClean International AB (publ), Annual General Meeting, Mar 21, 2025, at 08:00 W. Europe Standard Time. Location: at born advokater`s premises, strandvagen 7a, 102 45, stockholm. Sweden
New Risk • Dec 05New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: kr108.5m (US$9.97m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 39% per year over the past 5 years. Market cap is less than US$10m (kr108.5m market cap, or US$9.97m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr43m). Shareholders have been diluted in the past year (18% increase in shares outstanding).
Price Target Changed • Nov 16Price target increased by 437% to kr36.00Up from kr6.70, the current price target is provided by 1 analyst. New target price is 1,381% above last closing price of kr2.43. Stock is down 63% over the past year. The company posted a net loss per share of kr0.94 last year.
New Risk • Oct 27New major risk - Revenue and earnings growthEarnings have declined by 39% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 39% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr43m). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (kr207.5m market cap, or US$19.5m).
Reported Earnings • Oct 25Third quarter 2024 earnings: Revenues miss analyst expectationsThird quarter 2024 results: Revenue: kr14.1m (up 39% from 3Q 2023). Net loss: kr13.3m (loss widened 11% from 3Q 2023). Revenue missed analyst estimates by 36%. Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Sweden.
New Risk • Sep 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Swedish stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Negative equity (-kr8.1m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr40m). Currently unprofitable and not forecast to become profitable over next 2 years (kr10m net loss in 2 years). Share price has been volatile over the past 3 months (8.3% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (kr283.7m market cap, or US$27.8m).
Major Estimate Revision • Sep 06Consensus revenue estimates increase by 13%The consensus outlook for revenues in fiscal year 2024 has improved. 2024 revenue forecast increased from kr72.0m to kr81.4m. Forecast losses expected to reduce from -kr1.00 to -kr0.90 per share. Chemicals industry in Sweden expected to see average net income growth of 36% next year. Consensus price target up from kr6.70 to kr8.00. Share price rose 13% to kr5.94 over the past week.
Breakeven Date Change • Sep 03No longer forecast to breakevenThe analyst covering LifeClean International no longer expects the company to break even during the foreseeable future. The company was expected to make a profit of kr3.00m in 2026. New forecast suggests the company will make a loss of kr4.00m in 2026.
Price Target Changed • Sep 02Price target increased by 14% to kr8.00Up from kr7.00, the current price target is provided by 1 analyst. New target price is 45% above last closing price of kr5.50. Stock is up 0.7% over the past year. The company is forecast to post a net loss per share of kr0.90 next year compared to a net loss per share of kr0.94 last year.
Reported Earnings • Sep 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: kr21.0m (up 47% from 2Q 2023). Net loss: kr12.8m (loss widened 21% from 2Q 2023). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Sweden.
New Risk • Aug 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Swedish stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr44m). Currently unprofitable and not forecast to become profitable over next 2 years (kr3.8m net loss in 2 years). Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (5.0% increase in shares outstanding). Market cap is less than US$100m (kr221.9m market cap, or US$21.0m).
分析記事 • May 09LifeClean International (STO:LCLEAN) Is Making Moderate Use Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
New Risk • Apr 09New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr40m free cash flow). Earnings have declined by 42% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (6.3% increase in shares outstanding). Revenue is less than US$5m (kr53m revenue, or US$5.0m). Market cap is less than US$100m (kr430.9m market cap, or US$40.9m).
Reported Earnings • Feb 21Full year 2023 earnings released: kr0.94 loss per share (vs kr0.83 loss in FY 2022)Full year 2023 results: kr0.94 loss per share (further deteriorated from kr0.83 loss in FY 2022). Revenue: kr52.5m (up 11% from FY 2022). Net loss: kr44.2m (loss widened 23% from FY 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Chemicals industry in Sweden. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Board Member Petra Sas was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Price Target Changed • Nov 28Price target decreased by 29% to kr6.70Down from kr9.50, the current price target is provided by 1 analyst. New target price is 29% above last closing price of kr5.20. Stock is down 43% over the past year. The company posted a net loss per share of kr0.83 last year.
Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: kr10.4m (up 17% from 3Q 2022). Net loss: kr11.9m (loss widened 44% from 3Q 2022). Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Sweden.
New Risk • Aug 31New minor risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow. Free cash flow: -kr33m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr33m). Currently unprofitable and not forecast to become profitable over next 2 years (kr3.0m net loss in 2 years). Share price has been volatile over the past 3 months (9.5% average weekly change). Shareholders have been diluted in the past year (9.1% increase in shares outstanding). Revenue is less than US$5m (kr47m revenue, or US$4.3m). Market cap is less than US$100m (kr282.6m market cap, or US$25.8m).
New Risk • Jul 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Swedish stocks, typically moving 9.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (kr5.0m net loss in 2 years). Share price has been volatile over the past 3 months (9.5% average weekly change). Shareholders have been diluted in the past year (9.1% increase in shares outstanding). Revenue is less than US$5m (kr48m revenue, or US$4.5m). Market cap is less than US$100m (kr341.2m market cap, or US$32.4m).
Reported Earnings • Feb 19Full year 2022 earnings released: kr0.83 loss per share (vs kr0.83 loss in FY 2021)Full year 2022 results: kr0.83 loss per share (further deteriorated from kr0.83 loss in FY 2021). Revenue: kr48.3m (down 18% from FY 2021). Net loss: kr36.1m (loss widened 1.0% from FY 2021). Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in Sweden.
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Board Member Petra Sas was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 06Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: kr9.10m (down 21% from 3Q 2021). Net loss: kr8.31m (loss narrowed 1.3% from 3Q 2021). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Chemicals industry in Sweden.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. No independent directors (4 non-independent directors). Board member Jan Sjowall was the last director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Feb 18Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: kr0.78 loss per share (down from kr0.14 loss in FY 2020). Revenue: kr55.3m (up 69% from FY 2020). Net loss: kr32.8m (loss widened kr29.6m from FY 2020). Revenue missed analyst estimates by 52%.
Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a decent third quarter result with improved revenues, although losses increased and control over costs was weaker. Third quarter 2021 results: Revenue: kr12.1m (up 261% from 3Q 2020). Net loss: kr8.42m (loss widened 271% from 3Q 2020).
Reported Earnings • Aug 20Second quarter 2021 earnings released: kr0.15 loss per share (vs kr0.76 profit in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and control over costs. Second quarter 2021 results: Revenue: kr18.9m (down 3.2% from 2Q 2020). Net loss: kr6.36m (down 215% from profit in 2Q 2020).
Reported Earnings • May 07First quarter 2021 earnings releasedThe company reported a poor first quarter result with weaker earnings, revenues and control over costs. First quarter 2021 results: Revenue: kr12.0m (down 6.9% from 1Q 2020). Net loss: kr6.99m (down 338% from profit in 1Q 2020).
分析記事 • Apr 19LifeClean International AB (publ)'s (STO:LCLEAN) About To Shift From Loss To ProfitLifeClean International AB (publ) ( STO:LCLEAN ) is possibly approaching a major achievement in its business, so we...
Reported Earnings • Mar 29Full year 2020 earnings released: kr0.14 loss per shareThe company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: kr32.7m (up kr29.0m from FY 2019). Net loss: kr3.20m (loss narrowed 69% from FY 2019).
Reported Earnings • Feb 21Full year 2020 earnings released: kr0.14 loss per shareThe company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: kr32.7m (up kr29.0m from FY 2019). Net loss: kr3.20m (loss narrowed 69% from FY 2019).
Is New 90 Day High Low • Jan 27New 90-day low: kr9.60The company is down 6.0% from its price of kr10.25 on 28 October 2020. The Swedish market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
Is New 90 Day High Low • Jan 04New 90-day low: kr9.79The company is down 23% from its price of kr12.70 on 06 October 2020. The Swedish market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.
分析記事 • Jan 02Should LifeClean International AB (publ) (STO:LCLEAN) Focus On Improving This Fundamental Metric?One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
